Its upregulation in keloid tissue enhances cell growth and angiogenic activity, whereas H19 knockdown suppresses proliferation and downregulates mTOR and VEGF expression, identifying H19 as a key pro-fibrotic regulator and potential therapeutic target in keloid pathogenesis (Figure 3) (Zhang et al., 2016). The gene discussed is H19; the disease is keloid.